![]() Infinity Pharmaceuticals Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions. | ![]() Heidelberg Pharma Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries. | ||
Founding Date | Founding Date 2000 | Founding Date 1994 | Founding Date 1997 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Cambridge, US HQ | Locations Alameda, US HQ | Locations Ladenburg, DE HQ Ladenburg, DE |
Employees | Employees 25 | Employees 1,14712% decrease | Employees 60 |
Valuation ($) | Valuation ($) 726.1 k | Valuation ($) 8.2 b | Valuation ($) 158.3 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.6m (FY, 2022) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) €1.5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $83.7m (FY, 2025) | Cost of goods (€2.5m) (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $2.2b (FY, 2025) | Gross profit €6.3m (FY, 2025) |
Net income | Net income ($44.4m) (FY, 2022) | Net income $782.6m (FY, 2025) | Net income (€42.3m) (FY, 2025) |

Exelixis is an oncology company that develops cancer treatments.
View company
Heidelberg Pharma is a drug development company that provides pre-clinical drug discovery and development services for the development of anti-cancer and anti-inflammatory drugs to pharmaceutical and biotechnology industries.
View company